Horizon Investments, LLC Biogen Inc. Transaction History

Horizon Investments, LLC

$4.46 Billion
Q2 2024

A detailed history of Horizon Investments, LLC transactions in Biogen Inc. stock. As of the latest transaction made, Horizon Investments, LLC holds 2,698 shares of BIIB stock, worth $544,456. This represents 0.01% of its overall portfolio holdings.

Number of Shares

2,698

Previous 2,690 0.3%

Holding current value

$544,456

Previous $580,000 7.76%

% of portfolio

0.01%

Previous 0.01%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$190.52 - $236.72 $1,524 - $1,893	8 Added 0.3%	2,698 $625,000
Q1 2024 May 15, 2024	BUY	$212.02 - $267.71 $29,470 - $37,211	139 Added 5.45%	2,690 $580,000
Q4 2023 Feb 14, 2024	BUY	$222.59 - $267.94 $11,574 - $13,932	52 Added 2.08%	2,551 $660,000
Q3 2023 Nov 14, 2023	SELL	$253.3 - $285.89 $6,585 - $7,433	-26 Reduced 1.03%	2,499 $642,000
Q2 2023 Aug 14, 2023	BUY	$275.25 - $318.06 $4,954 - $5,725	18 Added 0.72%	2,525 $719,000
Q1 2023 May 15, 2023	SELL	$256.56 - $292.34 $237,831 - $270,999	-927 Reduced 26.99%	2,507 $697,000
Q4 2022 Feb 14, 2023	SELL	$252.44 - $306.72 $850,975 - $1.03 Million	-3,371 Reduced 49.54%	3,434 $951,000
Q3 2022 Nov 14, 2022	BUY	$194.69 - $268.46 $989,219 - $1.36 Million	5,081 Added 294.72%	6,805 $1.82 Million
Q2 2022 Aug 12, 2022	SELL	$187.54 - $223.02 $1.49 Million - $1.78 Million	-7,970 Reduced 82.22%	1,724 $352,000
Q1 2022 May 16, 2022	BUY	$193.77 - $244.14 $310,032 - $390,624	1,600 Added 19.77%	9,694 $2.04 Million
Q4 2021 Feb 15, 2022	SELL	$223.92 - $287.77 $55,532 - $71,366	-248 Reduced 2.97%	8,094 $1.94 Million
Q3 2021 Nov 15, 2021	BUY	$282.99 - $369.05 $138,382 - $180,465	489 Added 6.23%	8,342 $2.36 Million
Q2 2021 Aug 13, 2021	BUY	$259.0 - $414.71 $1.44 Million - $2.3 Million	5,551 Added 241.14%	7,853 $2.72 Million
Q1 2021 May 14, 2021	BUY	$242.95 - $284.63 $559,270 - $655,218	2,302 New	2,302 $644,000
Q4 2020 Feb 16, 2021	SELL	$236.26 - $355.63 $1.4 Million - $2.11 Million	-5,942 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$264.77 - $305.71 $1.32 Million - $1.52 Million	-4,984 Reduced 45.62%	5,942 $1.69 Million
Q2 2020 Aug 13, 2020	BUY	$258.66 - $342.55 $2.25 Million - $2.98 Million	8,693 Added 389.3%	10,926 $2.92 Million
Q1 2020 May 15, 2020	SELL	$268.85 - $341.04 $383,380 - $486,323	-1,426 Reduced 38.97%	2,233 $706,000
Q4 2019 Feb 14, 2020	BUY	$220.06 - $304.07 $525,503 - $726,119	2,388 Added 187.88%	3,659 $1.09 Million
Q3 2019 Nov 14, 2019	SELL	$217.44 - $243.88 $21,526 - $24,144	-99 Reduced 7.23%	1,271 $296,000
Q2 2019 Aug 14, 2019	BUY	$219.29 - $241.72 $60,524 - $66,714	276 Added 25.23%	1,370 $320,000
Q1 2019 May 16, 2019	BUY	$216.71 - $338.96 $237,080 - $370,822	1,094 New	1,094 $259,000

Others Institutions Holding BIIB

# of Institutions

1,050

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $29.1B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Horizon Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Horizon Investments, LLC with notifications on news.

Account

Horizon Investments, LLC Biogen Inc. Transaction History